|
US20020192198A1
(en)
*
|
1998-04-21 |
2002-12-19 |
Elia James P. |
Method for growing human organs and suborgans
|
|
US20030157074A1
(en)
*
|
1994-11-16 |
2003-08-21 |
Mitrani Eduardo N. |
Vitro micro-organs, and uses related thereto
|
|
US8075880B2
(en)
|
1999-01-11 |
2011-12-13 |
Steward St. Elizabeth's Medical Center Of Boston, Inc. |
Compositions and methods for regulating angiogenesis
|
|
US5980887A
(en)
*
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
|
ATE296117T1
(de)
*
|
1997-03-07 |
2005-06-15 |
Wistar Inst |
Verwendung von adenoviralen vektoren, die pdgf oder vegf exprimieren, zur heilung von gewebsdefekten und zur induzierung der hypervaskulität in säugergeweben
|
|
US7507705B2
(en)
*
|
1997-10-02 |
2009-03-24 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
|
|
US6749617B1
(en)
|
1997-11-04 |
2004-06-15 |
Scimed Life Systems, Inc. |
Catheter and implants for the delivery of therapeutic agents to tissues
|
|
US7687057B2
(en)
*
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
|
EP1060242A4
(en)
*
|
1998-01-23 |
2003-09-17 |
Imclone Systems Inc |
Purified populations of stem cells
|
|
US6676937B1
(en)
*
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
|
JP2002506008A
(ja)
*
|
1998-03-09 |
2002-02-26 |
セント エリザベス メディカル センター |
血管新生を調整するための組成物及び方法
|
|
US20040228834A1
(en)
*
|
1998-03-09 |
2004-11-18 |
Jeffrey Isner |
Compositions and methods for modulating vascularization
|
|
CA2266805C
(en)
|
1998-03-27 |
2015-04-28 |
An-Go-Gen Inc. |
Cell-based gene therapy in the treatment of pulmonary disorders
|
|
US9585916B2
(en)
|
1999-03-26 |
2017-03-07 |
Northern Therapeutics Inc. |
Cell based therapy for the pulmonary system
|
|
US6482406B1
(en)
|
1999-03-26 |
2002-11-19 |
Duncan J. Stewart |
Cell-based gene therapy for the pulmonary system
|
|
US6620382B1
(en)
|
1998-05-22 |
2003-09-16 |
Biopheresis Technologies, Llc. |
Method and compositions for treatment of cancers
|
|
US8197430B1
(en)
|
1998-05-22 |
2012-06-12 |
Biopheresis Technologies, Inc. |
Method and system to remove cytokine inhibitor in patients
|
|
US6352555B1
(en)
|
1998-07-10 |
2002-03-05 |
The Brigham And Womens Hospital, Inc. |
Methods for implanting cells
|
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
|
US6677300B1
(en)
*
|
1998-09-09 |
2004-01-13 |
Scios, Inc. |
Treatment of microvascular angiopathies
|
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
AU768330B2
(en)
*
|
1998-10-26 |
2003-12-11 |
Vegenics Limited |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
|
|
EP1568375A1
(en)
*
|
1998-10-26 |
2005-08-31 |
Ludwig Institute For Cancer Research |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
|
|
DE19850986A1
(de)
*
|
1998-11-05 |
2000-05-25 |
Aventis Pharma Gmbh |
Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen
|
|
EP1144594A1
(en)
*
|
1998-11-24 |
2001-10-17 |
Regents Of The University Of Minnesota |
Transgenic circulating endothelial cells
|
|
US20040131601A1
(en)
*
|
2000-03-30 |
2004-07-08 |
Foundry Networks, Inc., A Delaward Corporation |
Injection of bone marrow-derived cells and medium for angiogenesis
|
|
US6348050B1
(en)
*
|
1999-04-30 |
2002-02-19 |
Medtronic, Inc. |
Infusion systems for creating microenvironments in a living body
|
|
US20030152562A1
(en)
*
|
2001-10-23 |
2003-08-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Vitro micro-organs, and uses related thereto
|
|
US20050158289A1
(en)
*
|
1999-07-07 |
2005-07-21 |
Simmons Paul J. |
Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
|
|
US7670628B2
(en)
*
|
1999-07-07 |
2010-03-02 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
|
AU2003901668A0
(en)
|
2003-03-28 |
2003-05-01 |
Medvet Science Pty. Ltd. |
Non-haemopoietic precursor cells
|
|
US8062675B2
(en)
*
|
1999-07-07 |
2011-11-22 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
|
AUPQ147799A0
(en)
*
|
1999-07-07 |
1999-07-29 |
Medvet Science Pty. Ltd. |
Mesenchymal precursor cell
|
|
CA2380635A1
(en)
*
|
1999-08-19 |
2001-02-22 |
Stem Cell Pharmaceuticals, Inc. |
Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
|
|
US20020193301A1
(en)
|
1999-08-19 |
2002-12-19 |
Stem Cell Pharmaceuticals, Inc. |
TGF-alpha polypeptides, functional fragments and methods of use therefor
|
|
EP1220679B1
(en)
*
|
1999-09-23 |
2007-06-13 |
An-Go-Gen Inc. |
Cell-based gene therapy for the pulmonary system
|
|
AU778826B2
(en)
*
|
1999-10-29 |
2004-12-23 |
Anges Mg, Inc. |
Gene therapy for diabetic ischemic disease
|
|
US6379708B1
(en)
*
|
1999-11-20 |
2002-04-30 |
Cytologic, Llc |
Method for enhancing immune responses in mammals
|
|
US9522217B2
(en)
*
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US9364565B2
(en)
*
|
2000-03-15 |
2016-06-14 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods of using same
|
|
CA2400319C
(en)
|
2000-03-15 |
2008-09-16 |
Orbus Medical Technologies Inc. |
Coating that promotes endothelial cell adherence
|
|
US8088060B2
(en)
*
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US20070055367A1
(en)
*
|
2000-03-15 |
2007-03-08 |
Orbus Medical Technologies, Inc. |
Medical device with coating that promotes endothelial cell adherence and differentiation
|
|
US8460367B2
(en)
*
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US20030229393A1
(en)
*
|
2001-03-15 |
2003-12-11 |
Kutryk Michael J. B. |
Medical device with coating that promotes cell adherence and differentiation
|
|
US20030104977A1
(en)
*
|
2000-03-31 |
2003-06-05 |
Ugo Ripamonti |
Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
|
|
US20070111935A1
(en)
*
|
2000-04-06 |
2007-05-17 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US7166280B2
(en)
*
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
|
US10281478B2
(en)
|
2000-04-06 |
2019-05-07 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US20050277576A1
(en)
*
|
2000-04-06 |
2005-12-15 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
|
US9694038B2
(en)
*
|
2000-04-06 |
2017-07-04 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US6800298B1
(en)
*
|
2000-05-11 |
2004-10-05 |
Clemson University |
Biological lubricant composition and method of applying lubricant composition
|
|
MXPA02012067A
(es)
|
2000-06-05 |
2004-08-19 |
Univ Columbia |
Identificacion y uso de celulas endoteliales precursoras derivadas de medula osea par mejorar la funcion del miocardio despues de dano isquemico.
|
|
EP1303588B1
(en)
*
|
2000-07-26 |
2012-10-24 |
Boston Scientific Limited |
Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
|
|
AU2002253785A1
(en)
*
|
2000-11-08 |
2003-03-03 |
Boston Scientific Limited |
Catheter and implants for the delivery of therapeutic agents to tissues
|
|
US7029209B2
(en)
|
2000-12-18 |
2006-04-18 |
Cardemon, Inc. |
Slidable boring tool with fine adjustment
|
|
US7824680B2
(en)
*
|
2001-08-06 |
2010-11-02 |
The Regents Of The University Of California |
Methods for inhibiting angiogenesis
|
|
WO2003013570A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Cornell Research Foundation, Inc. |
Platelet-derived growth factor protection of cardiac myocardium
|
|
US7217570B2
(en)
*
|
2001-08-23 |
2007-05-15 |
The Wistar Institute Of Anatomy And Biology |
Organotypic intestinal culture and methods of use thereof
|
|
US20030054331A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Stemsource, Inc. |
Preservation of non embryonic cells from non hematopoietic tissues
|
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
|
US20040044403A1
(en)
*
|
2001-10-30 |
2004-03-04 |
Joyce Bischoff |
Tissue-engineered vascular structures
|
|
KR100969344B1
(ko)
*
|
2001-11-05 |
2010-07-09 |
메드제닉스 인코포레이티드 |
조직 기재 치료를 위한 폐쇄된 자동화 시스템, 이를 이용한 투약 및 투여 방법
|
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
|
US7595043B2
(en)
*
|
2001-12-07 |
2009-09-29 |
Cytori Therapeutics, Inc. |
Method for processing and using adipose-derived stem cells
|
|
US8404229B2
(en)
*
|
2001-12-07 |
2013-03-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to treat acute tubular necrosis
|
|
US20030161816A1
(en)
|
2001-12-07 |
2003-08-28 |
Fraser John K. |
Systems and methods for treating patients with processed lipoaspirate cells
|
|
US20060204556A1
(en)
*
|
2001-12-07 |
2006-09-14 |
Cytori Therapeutics, Inc. |
Cell-loaded prostheses for regenerative intraluminal applications
|
|
US7651684B2
(en)
|
2001-12-07 |
2010-01-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
|
|
US7771716B2
(en)
|
2001-12-07 |
2010-08-10 |
Cytori Therapeutics, Inc. |
Methods of using regenerative cells in the treatment of musculoskeletal disorders
|
|
US20050048035A1
(en)
|
2001-12-07 |
2005-03-03 |
Fraser John K. |
Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
|
|
US9597395B2
(en)
|
2001-12-07 |
2017-03-21 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
US7585670B2
(en)
*
|
2001-12-07 |
2009-09-08 |
Cytori Therapeutics, Inc. |
Automated methods for isolating and using clinically safe adipose derived regenerative cells
|
|
US20050008626A1
(en)
*
|
2001-12-07 |
2005-01-13 |
Fraser John K. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
US20050095228A1
(en)
|
2001-12-07 |
2005-05-05 |
Fraser John K. |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
|
US7514075B2
(en)
*
|
2001-12-07 |
2009-04-07 |
Cytori Therapeutics, Inc. |
Systems and methods for separating and concentrating adipose derived stem cells from tissue
|
|
CN1620306A
(zh)
*
|
2001-12-20 |
2005-05-25 |
马克罗珀尔公司 |
采用从脂肪组织中提取的富含胶原的物质治疗病人的系统和方法
|
|
JP2005514062A
(ja)
*
|
2001-12-21 |
2005-05-19 |
イミュネックス・コーポレーション |
内皮幹細胞、該細胞集団、該細胞の単離法および使用法
|
|
US20030139333A1
(en)
*
|
2002-01-18 |
2003-07-24 |
Genetix Pharmaceuticals, Inc. |
Methods and compositions for promoting angiogenesis
|
|
US20040009146A1
(en)
*
|
2002-02-26 |
2004-01-15 |
Osvaldo Podhajcer |
Anti-tumor vaccine and method
|
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
|
US20040009158A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Washington University |
Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
|
|
EP1563058A4
(en)
*
|
2002-07-12 |
2005-12-28 |
Univ Singapore |
Haemangioblasts-Progenitor Cells
|
|
AU2003242967A1
(en)
*
|
2002-07-12 |
2004-02-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method and device for inducing biological processes by micro-organs
|
|
US20040052771A1
(en)
*
|
2002-07-12 |
2004-03-18 |
Lim Sai Kiang |
Hemangioblast progenitor cells
|
|
DE10234192B4
(de)
*
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
US20050271639A1
(en)
*
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
|
US20040037811A1
(en)
*
|
2002-08-22 |
2004-02-26 |
The Cleveland Clinic Foundation |
Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
|
|
WO2008121719A1
(en)
|
2007-03-30 |
2008-10-09 |
The Cleveland Clinic Foundation |
Method of treating ischemic disorders
|
|
US7470538B2
(en)
*
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
EP1583422B1
(en)
*
|
2002-12-05 |
2016-03-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
|
US8940292B2
(en)
|
2003-01-28 |
2015-01-27 |
Wake Forest University Health Sciences |
Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
|
|
US20040197310A1
(en)
*
|
2003-02-12 |
2004-10-07 |
Sanberg Paul R. |
Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction
|
|
EP1615996A4
(en)
*
|
2003-03-27 |
2006-11-15 |
Texase A & M University System |
USES OF VEGETABLE TOTHELIC GROWTH FACTOR AND COLLAGEN INDUCIBLE PROTEIN TYPE I (VCIP)
|
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US7641643B2
(en)
|
2003-04-15 |
2010-01-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
|
US20040247575A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
|
SG146666A1
(en)
*
|
2003-09-17 |
2008-10-30 |
Macropore Biosurgery Inc |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
|
WO2005033275A2
(en)
*
|
2003-09-29 |
2005-04-14 |
The Regents Of The University Of California |
Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
|
|
US8465453B2
(en)
*
|
2003-12-03 |
2013-06-18 |
Mayo Foundation For Medical Education And Research |
Kits, apparatus and methods for magnetically coating medical devices with living cells
|
|
US20090118817A1
(en)
*
|
2005-06-16 |
2009-05-07 |
Mayo Foundation For Medical Education And Research |
Magnetic Medical Apparatus, Kits, and Methods
|
|
DE102004004509B4
(de)
*
|
2004-01-23 |
2010-07-01 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
JP2007217283A
(ja)
*
|
2004-03-30 |
2007-08-30 |
Niigata Tlo:Kk |
血管新生促進剤および血管新生療法
|
|
US20050265980A1
(en)
|
2004-05-14 |
2005-12-01 |
Becton, Dickinson And Company |
Cell culture environments for the serum-free expansion of mesenchymal stem cells
|
|
AU2005251379B2
(en)
|
2004-06-01 |
2011-03-31 |
Kwalata Trading Limited |
In vitro techniques for use with stem cells
|
|
CA2574186A1
(en)
*
|
2004-08-13 |
2006-02-23 |
Medtronic, Inc. |
Isolation of endothelial progenitor cell subsets and methods for their use
|
|
CA2581237C
(en)
*
|
2004-09-24 |
2018-11-06 |
Angioblast Systems, Inc. |
Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc)
|
|
US7994131B2
(en)
*
|
2004-10-07 |
2011-08-09 |
Stem Cell Therapeutics Corp. |
Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
|
|
WO2006055743A2
(en)
*
|
2004-11-18 |
2006-05-26 |
Franco, Wayne |
Compbination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US20060110374A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Dudy Czeiger |
Method to accelerate stem cell recruitment and homing
|
|
WO2006060779A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Case Western Reserve University |
Novel methods, compositions and devices for inducing neovascularization
|
|
JP5138384B2
(ja)
*
|
2005-01-10 |
2013-02-06 |
サイトリ セラピューティクス インコーポレイテッド |
医療装置を監視し、管理し、サービスするための装置及び方法
|
|
US20090215782A1
(en)
*
|
2005-04-18 |
2009-08-27 |
Carlo Foresta |
Use of PDE-5 Inhibitors for Endothelial Repair of Tissues Impaired by Trauma or Disease
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
US8828433B2
(en)
*
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
FR2889200B1
(fr)
*
|
2005-07-27 |
2008-01-04 |
Inst Vaisseaux Et Du Sang Ass |
Systeme marqueur cellulaire/ligand, ou le marqueur est du type eph, materiau cellulaire comprenant ce systeme, procede de preparation et utilisation proangiogenique
|
|
US20070065514A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Howell Mark D |
Method for enhancing immune responses in mammals
|
|
US7652922B2
(en)
*
|
2005-09-30 |
2010-01-26 |
Mosaid Technologies Incorporated |
Multiple independent serial link memory
|
|
US20070100323A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Ludwig Florian N |
Facilitation of endothelialization by in situ surface modification
|
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
SI1951864T1
(sl)
|
2005-11-07 |
2014-09-30 |
Amorcyte, Inc. |
Sestavki in postopki za reparacijo vaskularne poškodbe
|
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
|
TW200734462A
(en)
|
2006-03-08 |
2007-09-16 |
In Motion Invest Ltd |
Regulating stem cells
|
|
US7732190B2
(en)
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US9242005B1
(en)
*
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
US20080075690A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Mark Douglas Howell |
Method for enhancing immune responses in mammals
|
|
US20100034794A1
(en)
*
|
2006-10-03 |
2010-02-11 |
Van Der Strate Barry W A |
Endothelial progenitor cell compositions and neovascularization
|
|
WO2008085229A2
(en)
*
|
2006-11-15 |
2008-07-17 |
Arteriocyte Inc. |
Cell-based therapies for treating liver disease
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US8741326B2
(en)
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
|
FR2909559B1
(fr)
*
|
2006-12-06 |
2012-09-07 |
Inst Vaisseaux Et Du Sang |
Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
|
|
US20100040584A1
(en)
*
|
2006-12-19 |
2010-02-18 |
Children's Medical Center Corporation |
Methods for promoting neovascularization
|
|
US8137968B2
(en)
*
|
2007-02-28 |
2012-03-20 |
The Board Of Trustees Of The University Of Illinois |
Selected endothelial progenitor cells and methods for use
|
|
AU2008223817A1
(en)
*
|
2007-03-02 |
2008-09-12 |
National University Of Ireland, Galway |
Osteopontin for the prediction and treatment of cardiovascular diseases
|
|
US7632340B2
(en)
*
|
2007-03-07 |
2009-12-15 |
Hamilton Beach Brands, Inc. |
Air purifier for removing particles or contaminants from air
|
|
WO2008142862A1
(ja)
*
|
2007-05-18 |
2008-11-27 |
National University Corporation Asahikawa Medical College |
血管内皮前駆細胞の移植による抗がん療法
|
|
DK2162189T3
(da)
*
|
2007-06-13 |
2012-04-02 |
Univ Wake Forest Health Sciences |
Fremgangsmåde til helbredelse af erektil funktion
|
|
US20090053208A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Medtronic Vascular, Inc. |
Methods and Systems for Improving Tissue Perfusion
|
|
CA2709398C
(en)
*
|
2007-12-14 |
2017-11-07 |
The Cleveland Clinic Foundation |
Use of stromal cell-derived factor 1 for promoting wound healing
|
|
US11051733B2
(en)
|
2008-01-18 |
2021-07-06 |
Wake Forest University Health Sciences |
Isolating and purifying cells for therapy
|
|
US20090246179A1
(en)
*
|
2008-02-11 |
2009-10-01 |
The Cleveland Clinic Foundation |
Method of treating myocardial injury
|
|
US20100028311A1
(en)
*
|
2008-07-09 |
2010-02-04 |
Baxter International Inc. |
Using of scaffold comprising fibrin for delivery of stem cells
|
|
WO2010021993A1
(en)
|
2008-08-19 |
2010-02-25 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
|
WO2010065601A1
(en)
*
|
2008-12-03 |
2010-06-10 |
Amorcyte, Inc. |
Infarct area perfusion-improving compositions and methods of vascular injury repair
|
|
WO2010116665A1
(ja)
|
2009-04-07 |
2010-10-14 |
国立大学法人旭川医科大学 |
単核球由来の新規血管再生細胞群及びその分化誘導法
|
|
CN102458302B
(zh)
|
2009-05-01 |
2015-11-25 |
比米尼技术有限责任公司 |
用于优化组织和细胞富集的移植物的系统、方法和组合物
|
|
EP2473196B1
(en)
|
2009-08-28 |
2017-05-31 |
The Cleveland Clinic Foundation |
Sdf-1 delivery for treating ischemic tissue
|
|
JP2013506681A
(ja)
*
|
2009-10-02 |
2013-02-28 |
バクスター・インターナショナル・インコーポレイテッド |
腎損傷の処置における使用のための造血幹細胞
|
|
GB2487339A
(en)
|
2009-10-23 |
2012-07-18 |
Amorcyte Inc |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RS63430B1
(sr)
|
2010-10-01 |
2022-08-31 |
Modernatx Inc |
Ribonukleinske kiseline koje sadrže n1-metil-pseudouracile i njihove primene
|
|
EP2625264B1
(en)
|
2010-10-08 |
2022-12-07 |
Terumo BCT, Inc. |
Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
|
|
AU2011325871B2
(en)
*
|
2010-11-05 |
2016-02-04 |
Medvet Science Pty Ltd |
Markers of endothelial progenitor cells and uses thereof
|
|
EP2663868A2
(en)
|
2010-12-01 |
2013-11-20 |
The University of North Carolina at Chapel Hill |
Methods and compositions for targeting sites of neovascular growth
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK3682905T3
(da)
|
2011-10-03 |
2022-02-28 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer og anvendelser deraf
|
|
US9533010B2
(en)
|
2011-10-31 |
2017-01-03 |
Amorcyte, Llc |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
DE12858350T1
(de)
|
2011-12-16 |
2021-10-07 |
Modernatx, Inc. |
Modifizierte mrna zusammensetzungen
|
|
EP2817014A2
(en)
|
2012-02-21 |
2014-12-31 |
Baxter International Inc |
Pharmaceutical composition comprising cd34+ cells
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
HK1206601A1
(en)
|
2012-04-02 |
2016-01-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
HRP20220607T1
(hr)
|
2012-11-26 |
2022-06-24 |
Modernatx, Inc. |
Terminalno modificirana rna
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
WO2015051214A1
(en)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
EP3068866B1
(en)
|
2013-11-16 |
2018-04-25 |
Terumo BCT, Inc. |
Expanding cells in a bioreactor
|
|
WO2015148704A1
(en)
|
2014-03-25 |
2015-10-01 |
Terumo Bct, Inc. |
Passive replacement of media
|
|
US20160090569A1
(en)
|
2014-09-26 |
2016-03-31 |
Terumo Bct, Inc. |
Scheduled Feed
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
WO2017205667A1
(en)
|
2016-05-25 |
2017-11-30 |
Terumo Bct, Inc. |
Cell expansion
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
CN110612344B
(zh)
|
2017-03-31 |
2023-09-12 |
泰尔茂比司特公司 |
细胞扩增
|
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
|
US12234441B2
(en)
|
2017-03-31 |
2025-02-25 |
Terumo Bct, Inc. |
Cell expansion
|
|
WO2022204315A1
(en)
|
2021-03-23 |
2022-09-29 |
Terumo Bct, Inc. |
Cell capture and expansion
|
|
US12209689B2
(en)
|
2022-02-28 |
2025-01-28 |
Terumo Kabushiki Kaisha |
Multiple-tube pinch valve assembly
|
|
USD1099116S1
(en)
|
2022-09-01 |
2025-10-21 |
Terumo Bct, Inc. |
Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
|